Correction: Role of Absent in Melanoma (AIM2) Inflammasome and Proinflammatory Cytokines (Interleukin-18 and 33) in the Pathogenesis of Rheumatoid Arthritis in Iraqi population

Abstract

This corrects: Dhaidan S, Al-Ghurabi BH, Al-Jubouri RH. "Role of Absent in Melanoma (AIM2) Inflammasome and Proinflammatory Cytokines (Interleukin-18 and 33) in the Pathogenesis of Rheumatoid Arthritis in Iraqi population." Adv. Life Sci. 2025;12(3):558–563. doi: 10.62940/als.v12i3.2153.

Following publication of this article, it was identified that four references cited in the manuscript were unrelated to the subject matter of the article and/or the context in which they were cited. The incorrect references have been replaced by the authors as follows:

Reference 25, cited in support of a statement on the average patient age of the study cohort relative to the reported peak age range for RA prevalence:

Original (irrelevant) reference: Ahmad ST, Joyce MV, Boggess B, O'Tousa JE. The role of Drosophila ninaG oxidoreductase in visual pigment chromophore biogenesis. Journal of Biological Chemistry, (2006); 281(14): 9205–9209.

Replaced with: Mohammed Jasim E, Khudhur Jameel S, Ihsan Awadh N. Estimation of Interleukin 32 and Interleukin 37 Serum Levels in Iraqi Patients with Rheumatoid Arthritis. Archives of Razi Institute, (2023); 78(2): 743–750.

Reference 31, cited in support of a statement on sex-based prevalence differences in RA among Iraqi cohorts:

Original (irrelevant) reference: Taha GI. Involvement of IL-10 gene polymorphism (rs1800896) and IL-10 level in the development of peri-implantitis. Minerva Dental and Oral Science, (2024); 73(5): 264–271.

Replaced with: Khidhir RM, Al-Jubouri RH. The study of temporomandibular joint disorders and anti-cyclic citrullinated peptide antibodies in serum and saliva of patients with rheumatoid arthritis. Journal of Baghdad College of Dentistry, (2013); 25(Special Issue): 67–71.

Reference 32, cited in the same context as Reference 31:

Original (irrelevant) reference: Talib EQ, Taha GI. Involvement of interleukin-17A (IL-17A) gene polymorphism and interleukin-23 (IL-23) level in the development of peri-implantitis. BDJ Open, (2024); 10(1): 1–8.

Replaced with: Jassim NA, Ibrahim DH, Gorial FI. Efficacy and Safety of Etanercept in Severely Active Rheumatoid Arthritis: 6-month, Open Label, Prospective, Observational Study from Iraq. JNSR, (2015); 5(2): 120–124.

Reference 39, cited in support of a statement on salivary IL-18 levels in RA patients compared with controls:

Original (irrelevant) reference: Talib EQ, Taha GI, Ali DM, Al-Hindawi SH, Al-Khayat FAA, et al. The microbial boundaries in peri-implantitis: A review of pathogen-related advances. Folia Medica, (2024); 66(6): 763–769.

Replaced with: Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular Mitochondrial DNA and Oxidatively Damaged DNA in Synovial Fluid of Patients With Rheumatoid Arthritis. Arthritis Research & Therapy, (2003); 5(5): 234–240.

The authors have confirmed that these errors occurred during the final proofreading and correction stage of manuscript preparation and take full responsibility for the oversight. This does not affect the study's findings, conclusions, or overall scientific validity.

The Advancements in Life Sciences Editorial Office apologizes for any inconvenience this may have caused.

Correction Published

07 July 2025: The necessary corrections have been carried out in the Version of Record.